Toll Free: 1-888-928-9744

Low Back Pain - Pipeline Review, H2 2017

Published: Oct, 2017 | Pages: 98 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Low Back Pain - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Pipeline Review, H2 2017, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.

Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants. 

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Low Back Pain - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Low Back Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 7, 10, 2, 1 and 4 respectively.

Low Back Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Low Back Pain (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Low Back Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Low Back Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Low Back Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Low Back Pain (Central Nervous System)

Reasons To Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Low Back Pain (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Low Back Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Low Back Pain - Overview 6 Low Back Pain - Therapeutics Development 7 Pipeline Overview 7 Pipeline by Companies 8 Products under Development by Companies 11 Low Back Pain - Therapeutics Assessment 13 Assessment by Target 13 Assessment by Mechanism of Action 15 Assessment by Route of Administration 17 Assessment by Molecule Type 19 Low Back Pain - Companies Involved in Therapeutics Development 21 Ache Laboratorios Farmaceuticos SA 21 Adynxx Inc 21 AnGes MG Inc 21 Array BioPharma Inc 22 Axsome Therapeutics Inc 22 Boehringer Ingelheim GmbH 23 Egalet Corp 23 Frontier Biotechnologies Inc 24 Gador SA 24 Grunenthal GmbH 24 Hisamitsu Pharmaceutical Co Inc 25 Immune Pharmaceuticals Inc 25 MD Biosciences GmbH 26 Mesoblast Ltd 26 Nektar Therapeutics 27 Orion Corporation 27 Pacira Pharmaceuticals Inc 28 Pfizer Inc 28 Regeneron Pharmaceuticals Inc 29 Stayble Therapeutics AB 29 Sun Pharma Advanced Research Company Ltd 30 Low Back Pain - Drug Profiles 31 (acetaminophen + caffeine + diclofenac sodium + orphenadrine) - Drug Profile 31 (clonidine hydrochloride + naltrexone hydrochloride) - Drug Profile 32 (diclofenac sodium + lidocaine hydrochloride) - Drug Profile 33 (loxoprofen + methocarbamol) - Drug Profile 34 AB-001 - Drug Profile 35 AMG-0101 - Drug Profile 36 ARRY-954 - Drug Profile 38 AYX-2 - Drug Profile 39 bupivacaine ER - Drug Profile 40 cebranopadol - Drug Profile 43 dexmedetomidine hydrochloride - Drug Profile 47 fasinumab - Drug Profile 50 HP-3150 - Drug Profile 54 IG-8801 - Drug Profile 55 lidocaine hydrochloride - Drug Profile 56 MD-22 - Drug Profile 58 MPC-06ID - Drug Profile 59 NKTR-181 - Drug Profile 63 oxycodone hydrochloride ER - Drug Profile 69 SPARC-1401 - Drug Profile 72 STA-001 - Drug Profile 73 STA-363 - Drug Profile 74 tanezumab - Drug Profile 75 zoledronic acid - Drug Profile 79 Low Back Pain - Dormant Projects 82 Low Back Pain - Discontinued Products 84 Low Back Pain - Product Development Milestones 85 Featured News & Press Releases 85 Appendix 95 Methodology 95 Coverage 95 Secondary Research 95 Primary Research 95 Expert Panel Validation 95 Contact Us 95 Disclaimer 96
List of Tables
Number of Products under Development for Low Back Pain, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Low Back Pain - Pipeline by Ache Laboratorios Farmaceuticos SA, H2 2017 Low Back Pain - Pipeline by Adynxx Inc, H2 2017 Low Back Pain - Pipeline by AnGes MG Inc, H2 2017 Low Back Pain - Pipeline by Array BioPharma Inc, H2 2017 Low Back Pain - Pipeline by Axsome Therapeutics Inc, H2 2017 Low Back Pain - Pipeline by Boehringer Ingelheim GmbH, H2 2017 Low Back Pain - Pipeline by Egalet Corp, H2 2017 Low Back Pain - Pipeline by Frontier Biotechnologies Inc, H2 2017 Low Back Pain - Pipeline by Gador SA, H2 2017 Low Back Pain - Pipeline by Grunenthal GmbH, H2 2017 Low Back Pain - Pipeline by Hisamitsu Pharmaceutical Co Inc, H2 2017 Low Back Pain - Pipeline by Immune Pharmaceuticals Inc, H2 2017 Low Back Pain - Pipeline by MD Biosciences GmbH, H2 2017 Low Back Pain - Pipeline by Mesoblast Ltd, H2 2017 Low Back Pain - Pipeline by Nektar Therapeutics, H2 2017 Low Back Pain - Pipeline by Orion Corporation, H2 2017 Low Back Pain - Pipeline by Pacira Pharmaceuticals Inc, H2 2017 Low Back Pain - Pipeline by Pfizer Inc, H2 2017 Low Back Pain - Pipeline by Regeneron Pharmaceuticals Inc, H2 2017 Low Back Pain - Pipeline by Stayble Therapeutics AB, H2 2017 Low Back Pain - Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2017 Low Back Pain - Dormant Projects, H2 2017 Low Back Pain - Dormant Projects, H2 2017 (Contd..1), H2 2017 Low Back Pain - Discontinued Products, H2 2017



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2000
Multi User - US $4000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify